根据乳腺癌手术和放射治疗定位局部和区域复发的位置:EORTC 22922/10925 研究结果
该研究基于 EORTC 22922/10925 试验中 4004 例患者的数据,中位随访 15.7 年,评估手术范围和放射治疗对局部复发(LR)和区域复发(RR)发生率及部位的影响。结果显示,全乳切除术后 15 年 LR 累积发生率低于保乳手术+放疗(3.1% vs 7.3%,HR=0.421,95%CI=0.282-0.628,P<0.0001)。局部区域治疗的范围显著影响 LR 和 RR 的发生率及空间位置。
要点
- 全乳切除术后 15 年 LR 累积发生率为 3.1%,低于保乳手术+放疗的 7.3%(HR=0.421,95%CI=0.282-0.628,P<0.0001)。
- 保乳手术+放疗后 LR 在 3 年后仍以稳定速率持续发生,而全乳切除术后未观察到此现象。
- 复发空间位置与所采用的局部区域治疗相关,放疗的绝对获益与疾病分期和手术范围相关。
核心结论
- 局部区域治疗的范围显著影响局部复发和区域复发的发生率及空间位置。
研究设计与样本
- 研究数据全部提取自 EORTC 22922/10925 试验的个体患者病例报告表,中位随访 15.7 年。
- 采用考虑竞争风险的累积发生率曲线描述局部复发和区域复发,并使用 Fine & Gray 模型探索手术和放疗范围对局部复发率的影响,校正基线患者和疾病特征,显著性水平设为 5%(双侧)。
- 试验共纳入 4004 例患者。
主要发现
- 4004 例患者中,282 例(7%)发生局部复发,165 例(4.1%)发生区域复发。
- 全乳切除术后 15 年局部复发累积发生率为 3.1%,低于保乳手术+放疗的 7.3%(F&G:HR=0.421,95%CI=0.282-0.628,P<0.0001)。
- 全乳切除术后和保乳手术+放疗后局部复发在 3 年内发生率相似,但 3 年后仅保乳手术+放疗组以稳定速率继续发生局部复发。
- 复发的空间位置与所采用的局部区域治疗相关,放疗的绝对获益与疾病分期和手术范围相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The purpose of this study is to evaluate the influence of the extent of surgery and radiation therapy (RT) on the rates and sites of local (LR) and regional recurrences (RR) in the EORTC 22922/10925 trial. PATIENTS AND METHODS: All data were extracted from the trial's individual patients' case report forms (CRF) and analysed with a median follow-up of 15.7 years. Cumulative incidence curves were produced for LR and RR accounting for competing risks: an exploratory analysis of the effect of the extent of surgical and radiation treatments on LR rate was conducted using the Fine & Gray model accounting for competing risks and adjusted for baseline patient and disease characteristics. The significance level was set at 5%, 2-sided. Frequency tables were used to describe the spatial location of LR and RR. RESULTS: Out of 4004 patients included in the trial, 282 (7%) patients experienced LR and 165 (4.1%) RR, respectively. Cumulative incidence rate of LR at 15 years was lower after mastectomy (3.1%) compared to BCS + RT (7.3%) (F&G: HR (Hazard Ratio) = 0.421, 95%CI = 0.282-0.628, p-value < 0.0001). LR were similar up to 3 years for both mastectomy and BCS but continued to occur at a steady rate for BCS + RT, only. The spatial location of the recurrence was related to the locoregional therapy applied and the absolute gain of RT correlated to stage of disease and extent of surgery. CONCLUSIONS: The extent of locoregional therapies impacts significantly on LR and RR rates and spatial location.
引用
- Kaidar-Person O, Giasafaki P, Boersma L, et al. Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: Results from EORTC 22922/10925. Radiother Oncol. 2023. PMID: 37211281. doi:10.1016/j.radonc.2023.109698
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。